Schizophrenia News and Research

Latest Schizophrenia News and Research

Braeburn, Camurus announce FDA Fast Track designation for CAM2038 to treat opioid addiction

Braeburn Pharmaceuticals and Camurus announced today that the U.S. Food and Drug Administration granted Fast Track designation for the CAM2038 weekly and monthly buprenorphine subcutaneous injection products under development for the treatment of opioid addiction.

5 Nov 2015

General psychiatric support warranted in MS patients

Multiple sclerosis has a nonspecific effect on psychiatric morbidity, increasing the risk of all psychiatric disorders, shows a large population-based study.

3 Nov 2015

People with psychosis and addiction disorder may respond better to disorder-specific treatment

People with psychosis often develop an addiction disorder: almost one in two patients with schizophrenia are affected once during their lifetime. Patients with a dual diagnosis mostly have a poorer prognosis, and their disorder often becomes chronic.

31 Oct 2015

FAU, Max Planck ink new agreement to recruit and retain promising scientists

Florida Atlantic University, the Max Planck Florida Institute for Neuroscience and the Max Planck Society based in Germany, have signed an innovative agreement to facilitate a research and education program that will recruit promising scientists to MPFI and FAU.

30 Oct 2015

Pre-clinical study demonstrates positive effects of advanced prebiotic on neuro-inflammation, anxiety

Clasado Biosciences Limited, the producers and suppliers of the second generation prebiotic Bimuno(R) (B-GOS), a unique trans-galactooligosaccharide, and the Department of Psychiatry, University of Oxford, today announce the results of their latest pre-clinical study demonstrating a major role of the unique carbohydrate complex Bimuno against neuro-inflammation and anxiety.

28 Oct 2015

MHS receives CMMI grant to provide comprehensive healthcare to people with severe mental illness

Montefiore Health System today announced receipt of a four-year, $9.6 million grant from the Center for Medicare and Medicaid Innovation (CMMI) to fund a unique patient-centered approach to providing comprehensive healthcare to those with severe mental illness (SMI).

23 Oct 2015

3-D model of animal brain provides more complete picture of brain's connectivity

The animal brain is so complex, it would take a supercomputer and vast amounts of data to create a detailed 3-D model of the billions of neurons that power it.

23 Oct 2015

Thalamic reticular nucleus responsible for the brain's ability to multitask, study reveals

Researchers at NYU Langone Medical Center say they have added to evidence that a shell-shaped region in the center of the mammalian brain, known as the thalamic reticular nucleus or TRN, is likely responsible for the ability to routinely and seamlessly multitask.

22 Oct 2015

Scientists map out the brain circuitry critical for filtering out distractions

In a study of mice, scientists discovered that a brain region called the thalamus may be critical for filtering out distractions. The study, published in Nature and partially funded by the National Institutes of Health, paves the way to understanding how defects in the thalamus might underlie symptoms seen in patients with autism, attention deficit hyperactivity disorder (ADHD), and schizophrenia.

22 Oct 2015

Team-based, coordinated specialty care approach produces better outcomes for people with first episode psychosis

New research shows that treating people with first episode psychosis with a team-based, coordinated specialty care approach produces better clinical and functional outcomes than typical community care. Investigators also found that treatment is most effective for people who receive care soon after psychotic symptoms begin.

20 Oct 2015

New study provides first clinical evidence on the serious toll human trafficking has on mental health

A new study by researchers from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King's College London provides the first clinical evidence on the toll human trafficking has on mental health, including high levels of post-traumatic stress disorder (PTSD) and depression, amongst a patient population in South London.

19 Oct 2015

New UCL study highlights genes associated with schizophrenia and obesity

Genes involved in schizophrenia and obesity have been highlighted in a new UCL study, which could lead to a better understanding of the DNA variants which affect risk of these conditions and aid the development of improved strategies for prevention and treatment.

18 Oct 2015

Omeros launches OMIDRIAssure program to provide expanded patient access to Omidria

Omeros Corporation today announced that it has launched OMIDRIAssure, a comprehensive reimbursement services program to provide expanded access to Omidria® (phenylephrine and ketorolac injection) 1% / 0.3% for cataract surgery patients and reimbursement assistance for physicians and facilities.

15 Oct 2015

Researchers match certain schizophrenia symptoms to features of the brain's anatomy

Using advanced brain imaging, researchers have matched certain behavioral symptoms of schizophrenia to features of the brain's anatomy. The findings, at Washington University School of Medicine in St. Louis, could be a step toward improving diagnosis and treatment of schizophrenia.

14 Oct 2015

Brain areas linked to social behaviors underdeveloped in youths with high functioning ASD

A team of UCLA scientists has found that brain areas linked to social behaviors are both underdeveloped and insufficiently networked in youths with high functioning autism spectrum disorder (ASD) compared to study participants without ASD.

14 Oct 2015

Lithium can be safe, effective for children suffering from bipolar disorder

A multicenter study of young patients with bipolar disorder provides what may be the most scientifically rigorous demonstration to date that lithium -- a drug used successfully for decades to treat adults with the condition -- can also be safe and effective for children suffering from it.

12 Oct 2015

New analysis finds illogical thoughts as most predictive of schizophrenia risk

Despite decades of study, schizophrenia has remained stubbornly difficult to diagnose in its earliest stage - between the appearance of symptoms and the development of the disorder. Now, a new analysis led by researchers at the UNC School of Medicine and the Renaissance Computing Institute identified illogical thoughts as most predictive of schizophrenia risk.

9 Oct 2015

Aristada (aripiprazole lauroxil) extended release injection approved to treat adults with schizophrenia

On October 5, the U.S. Food and Drug Administration approved Aristada (aripiprazole lauroxil) extended release injection to treat adults with schizophrenia. Aristada is administered by a health care professional every four to six weeks using an injection in the arm or buttocks.

9 Oct 2015

Vraylar (cariprazine) capsules now approved by FDA to treat schizophrenia, bipolar disorder in adults

The U.S. Food and Drug Administration today approved Vraylar (cariprazine) capsules to treat schizophrenia and bipolar disorder in adults.

9 Oct 2015

Brain & Behavior Research Foundation to honor nine scientists with Outstanding Achievement Prizes

The Brain & Behavior Research Foundation will honor nine scientists with its 2015 Outstanding Achievement Prizes for their work in schizophrenia, mood disorders, child and adolescent psychiatry, and cognitive neuroscience.

9 Oct 2015

Schizophrenia News and Research

Latest Schizophrenia News and Research

Braeburn, Camurus announce FDA Fast Track designation for CAM2038 to treat opioid addiction

General psychiatric support warranted in MS patients

People with psychosis and addiction disorder may respond better to disorder-specific treatment

FAU, Max Planck ink new agreement to recruit and retain promising scientists

Pre-clinical study demonstrates positive effects of advanced prebiotic on neuro-inflammation, anxiety

MHS receives CMMI grant to provide comprehensive healthcare to people with severe mental illness

3-D model of animal brain provides more complete picture of brain's connectivity

Thalamic reticular nucleus responsible for the brain's ability to multitask, study reveals

Scientists map out the brain circuitry critical for filtering out distractions

Team-based, coordinated specialty care approach produces better outcomes for people with first episode psychosis

New study provides first clinical evidence on the serious toll human trafficking has on mental health

New UCL study highlights genes associated with schizophrenia and obesity

Omeros launches OMIDRIAssure program to provide expanded patient access to Omidria

Researchers match certain schizophrenia symptoms to features of the brain's anatomy

Brain areas linked to social behaviors underdeveloped in youths with high functioning ASD

Lithium can be safe, effective for children suffering from bipolar disorder

New analysis finds illogical thoughts as most predictive of schizophrenia risk

Aristada (aripiprazole lauroxil) extended release injection approved to treat adults with schizophrenia

Vraylar (cariprazine) capsules now approved by FDA to treat schizophrenia, bipolar disorder in adults

Brain & Behavior Research Foundation to honor nine scientists with Outstanding Achievement Prizes

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Schizophrenia News and Research

Latest Schizophrenia News and Research

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in